SCHEMBL19909452

SCHEMBL19909452

N#Cc1c(-n2c3ccccc3c3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)cc32)cc(-c2ccncc2)cc1-n1c2ccccc2c2ccc(-c3ccc(C(F)(F)F)cc3C(F)(F)F)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.36
KIF11 P52732 3/20 0.35
S1PR1 P21453 2/20 0.35
S1PR3 Q99500 2/20 0.35
ALOX5AP P20292 2/20 0.34
FEN1 P39748 2/20 0.34
AR P10275 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP2C9 P11712 1/20 0.33
SCN9A Q15858 1/20 0.33
EPHX2 P34913 2/20 0.32
CYP19A1 P11511 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32
PIP4K2A P48426 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19919605 0.95 KIF11 (0.39) PDE10AKIF11S1PR1S1PR3ALOX5AP
SCHEMBL19909453 0.94 PDE10A (0.36) PDE10AKIF11S1PR1S1PR3ALOX5AP
SCHEMBL19913193 0.93 S1PR1 (0.34) PDE10AKIF11S1PR1S1PR3ALOX5AP
SCHEMBL20111559 0.91 KIF11 (0.39) PDE10AKIF11S1PR1S1PR3ALOX5AP
SCHEMBL19903551 0.91 KIF11 (0.37) PDE10AKIF11ALOX5APFEN1AR
SCHEMBL19913194 0.90 KIF11 (0.34) PDE10AKIF11S1PR1S1PR3ALOX5AP
SCHEMBL19909372 0.89 KIF11 (0.39) PDE10AKIF11S1PR1S1PR3ALOX5AP
SCHEMBL19919724 0.89 KIF11 (0.34) PDE10AKIF11S1PR1S1PR3ALDH1A1
SCHEMBL19909345 0.89 KIF11 (0.43) KIF11ALDH1A1MAPTSMN1; SMN2TDP1
SCHEMBL21414237 0.89 KIF11 (0.36) KIF11ALOX5APFEN1ARALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 PDE10A 2467/4885KIF11 3067/4885S1PR1 2957/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 PDE10A 4550/4885KIF11 3082/4885S1PR1 4351/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 PDE10A 2467/4885KIF11 3067/4885S1PR1 2957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.